Cargando…
Synergistic Effects of Targeted PI3K Signaling Inhibition and Chemotherapy in Liposarcoma
While liposarcoma is the second most common soft tissue malignant tumor, the molecular pathogenesis in this malignancy is poorly understood. Our goal was therefore to expand the understanding of molecular mechanisms that drive liposarcoma and identify therapeutically-susceptible genetic alterations....
Autores principales: | Guo, Shang, Lopez-Marquez, Hector, Fan, Kenneth C., Choy, Edwin, Cote, Gregory, Harmon, David, Nielsen, G. Petur, Yang, Cao, Zhang, Changqing, Mankin, Henry, Hornicek, Francis J., Borger, Darrell R., Duan, Zhenfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3973642/ https://www.ncbi.nlm.nih.gov/pubmed/24695632 http://dx.doi.org/10.1371/journal.pone.0093996 |
Ejemplares similares
-
Targeting DYRK1B suppresses the proliferation and migration of liposarcoma cells
por: Chen, Hua, et al.
Publicado: (2017) -
Tissue Microarray Immunohistochemical Detection of Brachyury Is Not a Prognostic Indicator in Chordoma
por: Zhang, Linlin, et al.
Publicado: (2013) -
ZNF93 Increases Resistance to ET-743 (Trabectedin; Yondelis®) and PM00104 (Zalypsis®) in Human Cancer Cell Lines
por: Duan, Zhenfeng, et al.
Publicado: (2009) -
miR‐15b modulates multidrug resistance in human osteosarcoma in vitro and in vivo
por: Duan, Zhenfeng, et al.
Publicado: (2016) -
Targeting programmed cell death ligand 1 by CRISPR/Cas9 in osteosarcoma cells
por: Liao, Yunfei, et al.
Publicado: (2017)